INTRODUCTION
BCC's goal in conducting this study was to determine the current status of the worldwide electrophoresis industry and to assess its growth potential from 2008 through 2013. We were particularly interested in understanding the current market scenario for both gel electrophoresis (GE) and capillary electrophoresis (CE) technologies. This report also assesses the growth and market potential for agarose and polyacrylamide gel electrophoresis techniques. As nucleic acid and protein separation are the two major applications, their market potential has also been examined. This market has been segmented into instrumentation, aftermarket supplies, and services; we were interested in monitoring trends in each of these segments. In addition, we were interested in analyzing the electrophoresis industry from end users' perspectives.
SCOPE OF STUDY
This report contains:
- Descriptions of electrophoresis techniques and technologies used in academia, government research laboratories, and the biopharmaceutical, environmental, chemical, forensics and food industries
- The current market status for electrophoresis technology, with trends and forecasts for growth over the next 5 years
- Technological issues including the latest trends and a thorough patent analysis
- Examination of the impact of lab-on-a-chip electrophoresis on the overall capillary electrophoresis technology segment
- Company profiles.
METHODOLOGY
BCC's methodology for market analysis and forecast projections made in the report encompassed primary and secondary data sources and calculations. Based on interaction with industry stakeholders and experts, we analyzed the potential of GE and CE technologies, product segments, end-users, and nucleic acid/protein electrophoresis applications. Revenue projections for the previous segments were developed and corroborated through primary interviews with respondents from participating organizations.
INFORMATION SOURCES
BCC interacted with over 35 electrophoresis manufacturers specializing in different product segments to obtain data for this study. In addition, data was also compiled from government and other public research data sources.
ANALYST CREDENTIALS
Charanya Ramachandran has been in the market research industry for the last 3 years. She holds a Master's degree in Biomedical Engineering from Texas A&M University, College Station. She previously held research positions in leading medical device companies in the U.S. Her major focus in health care market research is in drug discovery and diagnostics technologies.
Report Code: MST040B, Published: February 2008, Analyst: Vanita Khetan
